Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
- DOI
- 10.1007/s10067-026-08373-8
- Published
- 2026 Nov
- Container
- Clinical rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10067-026-08373-8,
title = {Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.},
author = {Iacono D and Raimondi M and Marino V and Riccio F and Marchesano ML and Milone A and Corrado A and Rotondo C and Firenze I and La Barbera L and Rizzo C and Montalbano S and Navarini L and Lo Gullo A and Oliva M and Favoino E and Orlando I and Cantatore FP and Cipriani P and Tirri E and Giacomelli R and Perosa F and Guggino G and Ruscitti P and Ciccia F},
year = {2026},
journal = {Clinical rheumatology},
doi = {10.1007/s10067-026-08373-8},
url = {https://doi.org/10.1007/s10067-026-08373-8}
}RIS
TY - JOUR TI - Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study. AU - Iacono D AU - Raimondi M AU - Marino V AU - Riccio F AU - Marchesano ML AU - Milone A AU - Corrado A AU - Rotondo C AU - Firenze I AU - La Barbera L AU - Rizzo C AU - Montalbano S AU - Navarini L AU - Lo Gullo A AU - Oliva M AU - Favoino E AU - Orlando I AU - Cantatore FP AU - Cipriani P AU - Tirri E AU - Giacomelli R AU - Perosa F AU - Guggino G AU - Ruscitti P AU - Ciccia F PY - 2026 JO - Clinical rheumatology DO - 10.1007/s10067-026-08373-8 UR - https://doi.org/10.1007/s10067-026-08373-8 ER -
APA
D, I., M, R., V, M., F, R., ML, M., A, M., A, C., C, R., I, F., L, L. B., C, R., S, M., L, N., A, L. G., M, O., E, F., I, O., FP, C., P, C., E, T., R, G., F, P., G, G., P, R., & F, C. (2026). Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08373-8
Source records
- pubmed · retrieved 2026-11-10T10:55:42.401Z
- europe-pmc · retrieved 2026-11-10T10:55:42.398Z